Agilent Technologies, Inc. (Santa Clara, California) Supports Research at the Broad Institute, Developing Proteomics Technology to Detect Disease Biomarkers

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and the Agilent Technologies Foundation today announced that Steven Carr, Ph.D, who directs the Proteomics Platform at the Broad Institute of MIT and Harvard, has been selected for an Agilent Thought Leader Award supporting his work developing new technology for analyzing proteins and peptides. Carr’s goal is to produce better techniques for diagnosing illnesses such as cardiovascular disease, breast cancer and ovarian cancer.